Cargando…
Prognostic Factors for Myositis-Associated Interstitial Lung Disease
BACKGROUND: Interstitial lung disease (ILD) is a common manifestation of polymyositis (PM), dermatomyositis (DM), and clinically amyopathic dermatomyositis (CADM); however, little is known about the factors influencing the prognosis for PM/DM/CADM-associated ILD. (PM/DM/CADM-ILD). The aim of the pre...
Autores principales: | Fujisawa, Tomoyuki, Hozumi, Hironao, Kono, Masato, Enomoto, Noriyuki, Hashimoto, Dai, Nakamura, Yutaro, Inui, Naoki, Yokomura, Koshi, Koshimizu, Naoki, Toyoshima, Mikio, Shirai, Toshihiro, Yasuda, Kazumasa, Hayakawa, Hiroshi, Suda, Takafumi |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4048238/ https://www.ncbi.nlm.nih.gov/pubmed/24905449 http://dx.doi.org/10.1371/journal.pone.0098824 |
Ejemplares similares
-
Acute exacerbation of rheumatoid arthritis-associated interstitial lung disease: mortality and its prediction model
por: Hozumi, Hironao, et al.
Publicado: (2022) -
Pulse oximetric saturation to fraction of inspired oxygen (SpO(2)/FIO(2)) ratio 24 hours after high-flow nasal cannula (HFNC) initiation is a good predictor of HFNC therapy in patients with acute exacerbation of interstitial lung disease
por: Koyauchi, Takafumi, et al.
Publicado: (2020) -
Prognostic and Clinical Value of Cluster Analysis in Idiopathic Pleuroparenchymal Fibroelastosis Phenotypes
por: Nakamura, Yutaro, et al.
Publicado: (2021) -
Prognostic significance of forced vital capacity decline prior to and following antifibrotic therapy in idiopathic pulmonary fibrosis
por: Aono, Yuya, et al.
Publicado: (2020) -
Low-dose Fluticasone Propionate in Combination With Salmeterol in Patients With Chronic Obstructive Pulmonary Disease
por: Yasui, Hideki, et al.
Publicado: (2018)